Clinical Trials
3 trialsNCT06823375 2026-03-04
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
Chinese University of Hong Kong
Phase 2 Recruiting
NCT05873244 2025-03-21
CXD101 in Immunotherapy-related Liver Cancer
Chinese University of Hong Kong
Phase 2 Recruiting
NCT06463444 2024-06-17
Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models
Tongji Hospital
Phase 1 Recruiting